🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patient with histologically proven NSCLC in a metastatic stage, treatment n...
Status
Recruiting
Location
Hopital Ambroise Pare
Start Date
2021-05-22
Trial ID
NCT04790682
Rates of local disease control in patients with locally advanced esophageal...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2019-11-07
Trial ID
NCT04046575
The purpose of this research study is to learn more about the inherited ris...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2023-01-01
Trial ID
NCT05587439
Treatments Being Tested
Total neoadjuvant treatment (TNT) including radiotherapy and induction or c...
Status
Recruiting
Location
CHU Dijon Bourgogne
Start Date
2025-02-06
Trial ID
NCT06762405
Treatments Being Tested
Leiomyosarcoma (LMS) is one of the most prevalent soft tissue sarcomas (STS...
Status
Recruiting
Location
Sarcoma Oncology Research Center
Start Date
2022-12-22
Trial ID
NCT05653388
Treatments Being Tested
This research study is studying a new blood test to screen for Epidermal Gr...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2025-04-01
Trial ID
NCT06716580
Treatments Being Tested
To evaluate the effectiveness and accuracy of the ctDNA dual-target test ki...
Status
Completed
Location
Changhai Hospital
Start Date
2022-10-21
Trial ID
NCT05508503
Treatments Being Tested
Due to the rapid growth, tumour demand for oxygen is often higher than what...
Status
Unknown
Location
The Christie NHS Foundation Trust
Start Date
2021-10-03
Trial ID
NCT05702619
Treatments Being Tested
Trial assessing the prognostic value of ctDNA mutations from samples taken ...
Status
Recruiting
Location
Institut Bergonie
Start Date
2017-10-06
Trial ID
NCT03357120
Treatments Being Tested
Up to 250 patients from anywhere in the United States can remotely consent ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2022-09-08
Trial ID
NCT05272423
Treatments Being Tested